Which pro-inflammatory cytokine is a key player in synovial inflammation in rheumatoid arthritis?

• A. IL-10
• B. TNF alpha
• C. IL-4
• D. TGF beta

Answer: (B)

In rheumatoid arthritis, the inflammation in the joint is driven by cytokines produced by immune cells in the synovium, and one stands out as the central organizer of this process: TNF-α. This cytokine acts as an early and powerful amplifier of inflammation. It stimulates endothelial cells to express adhesion molecules, which helps inflammatory cells flood into the joint. It also activates synovial fibroblasts and macrophages to produce other inflammatory mediators like IL-1 and IL-6, creating a self-sustaining cascade. TNF-α promotes the release of matrix metalloproteinases that break down cartilage and, through increasing RANKL expression, drives osteoclast activation and bone erosion. All of these actions contribute to the characteristic pannus formation that invades and destroys joint tissue.

The strength of TNF-α as the best answer is supported by clinical evidence: treatments that block TNF-α lead to marked reductions in joint inflammation, pain, and radiographic progression in many patients with RA, underscoring its pivotal role in the disease process.

Other cytokines mentioned play roles in immune regulation—such as IL-10, which tends to dampen inflammation, and IL-4, which promotes a Th2-biased response—and TGF-β, which has complex, context-dependent effects. While they influence RA in various ways, they are not the primary drivers of the synovial inflammation and joint destruction that TNF-α orchestrates.